Michael Halstead Intra Cellular Therapies, Inc. (ITCI) insider trading activity

Michael Halstead is President of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Dec 01, 2022, when has been sold 50,000 shares (Common Stock) at a price of $15.47 per share, resulting in proceeds of $773,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Michael Halstead Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2022	BUY Exercise of conversion of derivative security	$773,500 $15.47 p/Share	50,000 Added 50.0%	50,000 Common Stock
Feb 24 2022	SELL Open market or private sale	$411,112 $52.0 p/Share	7,906 Reduced 100.0%	0 Common Stock
Feb 23 2022	BUY Exercise of conversion of derivative security	-	7,906 Added 50.0%	7,906 Common Stock
Feb 22 2022	SELL Open market or private sale	$616,321 $55.33 p/Share	11,139 Reduced 100.0%	0 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	11,139 Added 50.0%	11,139 Common Stock
Jan 10 2022	SELL Open market or private sale	$803,039 $40.89 p/Share	19,639 Reduced 100.0%	0 Common Stock
Jan 08 2022	BUY Exercise of conversion of derivative security	-	19,639 Added 50.0%	19,639 Common Stock
Dec 21 2021	SELL Open market or private sale	$8,275,420 $46.79 p/Share	176,863 Reduced 100.0%	0 Common Stock
Dec 21 2021	BUY Exercise of conversion of derivative security	$2,780,286 $15.72 p/Share	176,863 Added 50.0%	176,863 Common Stock
Feb 19 2021	SELL Open market or private sale	$435,424 $39.09 p/Share	11,139 Reduced 100.0%	0 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	11,139 Added 50.0%	11,139 Common Stock
Jan 11 2021	SELL Open market or private sale	$625,667 $31.86 p/Share	19,638 Reduced 100.0%	0 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	-	19,638 Added 50.0%	19,638 Common Stock
Jan 04 2021	SELL Open market or private sale	$503,707 $31.17 p/Share	16,160 Reduced 100.0%	0 Common Stock
Jan 03 2021	BUY Exercise of conversion of derivative security	-	16,160 Added 50.0%	16,160 Common Stock
Nov 17 2020	SELL Open market or private sale	$2,206,427 $27.78 p/Share	79,425 Reduced 100.0%	0 Common Stock
Nov 17 2020	BUY Exercise of conversion of derivative security	$1,039,500 $13.86 p/Share	75,000 Added 48.57%	79,425 Common Stock

Michael Halstead

President

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Value

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intra-Cellular Therapies, Inc.

Track Activities on ITCI

Account